chr6-142753412-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_006734.4(HIVEP2):c.7036C>T(p.Leu2346Phe) variant causes a missense change. The variant allele was found at a frequency of 0.0037 in 1,613,938 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0027 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0038 ( 12 hom. )
Consequence
HIVEP2
NM_006734.4 missense
NM_006734.4 missense
Scores
1
6
12
Clinical Significance
Conservation
PhyloP100: 6.08
Publications
4 publications found
Genes affected
HIVEP2 (HGNC:4921): (HIVEP zinc finger 2) This gene encodes a member of a family of closely related, large, zinc finger-containing transcription factors. The encoded protein regulates transcription by binding to regulatory regions of various cellular and viral genes that maybe involved in growth, development and metastasis. The protein contains the ZAS domain comprised of two widely separated regions of zinc finger motifs, a stretch of highly acidic amino acids and a serine/threonine-rich sequence. [provided by RefSeq, Nov 2012]
HIVEP2 Gene-Disease associations (from GenCC):
- intellectual disability, autosomal dominant 43Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Illumina, G2P
- autosomal dominant non-syndromic intellectual disabilityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.006490886).
BP6
Variant 6-142753412-G-A is Benign according to our data. Variant chr6-142753412-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 445845.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 405 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HIVEP2 | NM_006734.4 | c.7036C>T | p.Leu2346Phe | missense_variant | Exon 10 of 10 | ENST00000367603.8 | NP_006725.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| HIVEP2 | ENST00000367603.8 | c.7036C>T | p.Leu2346Phe | missense_variant | Exon 10 of 10 | 1 | NM_006734.4 | ENSP00000356575.2 |
Frequencies
GnomAD3 genomes AF: 0.00265 AC: 404AN: 152190Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
404
AN:
152190
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00268 AC: 661AN: 246880 AF XY: 0.00285 show subpopulations
GnomAD2 exomes
AF:
AC:
661
AN:
246880
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00380 AC: 5561AN: 1461630Hom.: 12 Cov.: 31 AF XY: 0.00374 AC XY: 2722AN XY: 727104 show subpopulations
GnomAD4 exome
AF:
AC:
5561
AN:
1461630
Hom.:
Cov.:
31
AF XY:
AC XY:
2722
AN XY:
727104
show subpopulations
African (AFR)
AF:
AC:
13
AN:
33478
American (AMR)
AF:
AC:
59
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
52
AN:
26136
East Asian (EAS)
AF:
AC:
3
AN:
39700
South Asian (SAS)
AF:
AC:
183
AN:
86258
European-Finnish (FIN)
AF:
AC:
111
AN:
53168
Middle Eastern (MID)
AF:
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
4996
AN:
1112010
Other (OTH)
AF:
AC:
143
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
335
670
1005
1340
1675
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
184
368
552
736
920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00266 AC: 405AN: 152308Hom.: 1 Cov.: 32 AF XY: 0.00264 AC XY: 197AN XY: 74484 show subpopulations
GnomAD4 genome
AF:
AC:
405
AN:
152308
Hom.:
Cov.:
32
AF XY:
AC XY:
197
AN XY:
74484
show subpopulations
African (AFR)
AF:
AC:
26
AN:
41566
American (AMR)
AF:
AC:
20
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
3
AN:
3468
East Asian (EAS)
AF:
AC:
3
AN:
5176
South Asian (SAS)
AF:
AC:
14
AN:
4828
European-Finnish (FIN)
AF:
AC:
36
AN:
10616
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
301
AN:
68036
Other (OTH)
AF:
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
21
42
64
85
106
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
15
ALSPAC
AF:
AC:
21
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
30
ExAC
AF:
AC:
324
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
HIVEP2: BP4, BS2 -
Sep 01, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;.;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
P;P;P
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.